1. Introduction {#sec1}
===============

Intermittent exposure to mildly stressful situations is a feature of stress inoculation training for people who work in conditions where performance in the face of adversity is required, e.g., medical and military personnel, police, firefighters, and rescue workers ([@bib33], [@bib46], [@bib50]). Stress inoculation is further supported by evidence that mild but not minimal nor severe stress exposure promotes subsequent coping and emotion regulation as described by U-shaped functions ([@bib43], [@bib45], [@bib48]). Exposure psychotherapies likewise teach patients to imagine a graded series of stressful situations and encourage interaction with stressors *in vivo* ([@bib32]). These procedures promote learning ([@bib8]) and provide opportunities to practice acquired coping skills ([@bib49]).

Previously, we showed that stress inoculation early in life enhances subsequent coping and emotion regulation modeled in mice ([@bib4]) and squirrel monkeys ([@bib28], [@bib29]). In keeping with suggestions that emotion regulation is an aspect of cognitive control ([@bib7]), we also found that stress inoculation enhances cognitive control of impulsive motivated behavior ([@bib39], [@bib42]). Impaired cognitive control and dysregulation of motivation have been linked to low striatal dopamine D2 and/or D3 receptor (DRD2/3) levels in rodents, monkeys, and humans ([@bib9], [@bib16], [@bib35], [@bib51], [@bib55]). Conversely, increased experimental expression of dopamine D2 receptors in ventral striatum enhances motivation in mice ([@bib52]). High striatal DRD2/3 availability in humans is associated with resilience against the development of addictions ([@bib53], [@bib54]) and pharmacological DRD2/3 agonists decrease impulsive behavior in rats ([@bib14]). DRD2/3 agonists similarly improve reversal learning as an index of cognitive control in humans dependent on psychostimulant drugs ([@bib13]).

Here, we examine striatal DRD2/3 regulation by stress inoculation in female squirrel monkeys. Females are studied because stress-related mental health disorders are 2--3 times more common in women than men ([@bib1]). Impaired cognitive control of thoughts, feelings, and behavior is a key dimension of various psychiatric disorders in humans ([@bib15]) and neural mechanisms that mediate this dimension may provide novel targets for new treatment interventions. Based on our findings that cognitive control of impulsivity is improved in squirrel monkeys exposed early in life to stress inoculation ([@bib39], [@bib42]), we test for increased striatal DRD2/3 availability in stress inoculated squirrel monkeys studied as adults by measuring \[^11^C\]raclopride binding *in vivo* with positron emission tomography (PET).

2. Materials and methods {#sec2}
========================

Female squirrel monkeys (*Samiri sciureus*) that were born and raised at the Stanford University Research Animal Facility served as subjects. All squirrel monkeys were initially housed in undisturbed mixed-sex natal groups through 16 weeks of age. Group composition was determined by birth dates to minimize developmental differences between natal groups. Seasonal synchronous breeding facilitated the generation of age-matched groups.

Groups were housed indoors in 1.8 × 1.2 × 1.8 m species appropriate cages that were cleaned daily. Housing and testing occurred in climate controlled rooms with an ambient temperature of 26 °C. Light/dark cycles were 12:12 h with lights on at 0700 h. All squirrel monkeys were provided unrestricted access to fresh drinking water and monkey chow with fruit and vegetable supplements. Various toys, swinging perches, and simulated foraging activities were provided for environmental enrichment. To facilitate husbandry-related activities and experimental manipulations, squirrel monkeys were trained to leave the home cage through a small sliding door connected to a transport box used for capture and transportation. All procedures were approved by Stanford University\'s Administrative Panel on Laboratory Animal Care and were carried out in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.

2.1. Experimental design {#sec2.1}
------------------------

Squirrel monkeys were randomized to one of three 10-week treatment conditions that occurred between 17 and 27 week of age as described elsewhere in detail ([@bib38], [@bib40]). In the no-stress (NS) control condition, squirrel monkeys were continuously maintained in undisturbed natal groups. In the stress inoculation (SI) condition, squirrel monkeys were individually removed from natal groups once each week for 10 total 1-hr separation sessions ([@bib38]). In the SI + Mom condition, squirrel monkeys were treated identically except that each monkey along with its mother was removed together from natal groups once each week for 10 total 1-hr sessions ([@bib40]). After each social separation in the SI and SI + Mom conditions, squirrel monkeys were returned to the home cage and reunited with the natal group. All separations occurred between 1200 and 1800 h and no more than one squirrel monkey from each natal group was separated on a given day.

After completion of the treatment conditions at 27 week of age, behavioral measures of coping and emotion regulation were collected from all squirrel monkeys in the presence of mothers during involuntary exposure to a novel environment at 9 months of age ([@bib38], [@bib40]). Mothers were then permanently removed and their offspring were housed with peers. Cognitive control of impulsive behavior was examined in NS and SI squirrel monkeys at 1.5 and 3.5 years of age ([@bib39], [@bib42]). Novelty seeking was also assessed in NS and SI squirrel monkeys at 2.5 years of age ([@bib41]). Magnetic resonance imaging (MRI) of brain was conducted with NS and SI squirrel monkeys at 3.3 years of age ([@bib23]) and place preference conditioning tests of NS and SI squirrel monkeys were conducted at 4.4 years of age (unpublished observations). Cognitive control, novelty seeking, place preference conditioning, and previous neuroimaging procedures were not conducted with SI + Mom squirrel monkeys and provided the opportunity to assess stress inoculation versus subsequent testing effects. After 4.4 years of age, no tests were conducted with any of the squirrel monkeys except for procedures described below.

All females were housed separately from males in same-sex social groups beginning at puberty around 2.5 years of age to prevent breeding. Striatal DRD2/3 availability was assessed *in vivo* with PET using \[^11^C\]raclopride in 24 randomly selected females from the 3 rearing conditions: 9 NS, 7 SI, and 8 SI + Mom females at 11.2 years of age (range 10.5--11.7 years). Lifespan in captivity is ∼20 years ([@bib3]). All neuroimaging was conducted during non-breeding seasons when sex hormone levels remain stable at non-detectable levels in these seasonally breeding primates ([@bib47]).

2.2. \[^11^C\]raclopride radiosynthesis {#sec2.2}
---------------------------------------

\[^11^C\]raclopride was prepared in a GE TRACERlab FX C Pro module (GE Healthcare) using previously published methods ([@bib24]) with the following modifications. Briefly, \[^11^C\]carbon dioxide was delivered from a GE PETtrace cyclotron (GE Healthcare) into the synthetic module, where the methylating agent \[^11^C\]methyl triflate, was formed from \[^11^C\]carbon dioxide via reduction, halogenation, and triflation. \[^11^C\]Methyl triflate was bubbled with a flow rate of 20 mL/min into solution containing acetone (300 μl), *O*-Desmethyl free base precursor (1 mg, 3.3 μmol, ABX), and NaOH (3 μL, 1 N) at −20 °C. The reaction mixture was warmed to room temperature within 1 min, diluted with 1 mL water, and loaded on a semi-preparative HPLC column for purification (Phenomenex Luna C18 5 micro, 250 × 10 mm, 30% acetonitrile, 70% 0.1 M NH~4~HCO~2~ with 0.5% AcOH, 7 mL/min). The fraction corresponding to \[^11^C\]raclopride (Rt = 9.2 min) was collected in a round flask preloaded with 20 mL water. Mobile phase was removed using a solid phase extraction (SPE) process, then \[^11^C\]raclopride was eluted from the SPE cartridge with ethanol and subsequent dilution with saline (ethanol \< 10% *v*/*v*). Final \[^11^C\]raclopride for imaging was sterilized by passing it through a 0.22 μm Millex MP (33 mm) sterile filter. Overall synthesis time was 45 min and radiochemical yield of \[^11^C\]raclopride was 2.0 ± 0.6% (n = 40). Analytical HPLC (Phenomenex Gemini C18 5 micro, 250 × 4.6 mm, 60% acetonitrile, 40% 0.1 M NH~4~HCO~2~ with 0.5% AcOH, 1 mL/min) showed the final product (Rt = 7.8 min) to have \>99% radiochemical and chemical purities and high specific activity (10.6 ± 3.9 Ci/μmol; n = 40). Both radiochemical yield and specific activity were decay-corrected to the end of synthesis.

2.3. Neuroimaging {#sec2.3}
-----------------

Whole brain anatomical and \[^11^C\]raclopride data were acquired with established methods. Each squirrel monkey was fasted overnight and then sedated with an intramuscular injection of 10 mg/kg ketamine hydrochloride. Atropine sulfate was subcutaneously administered at 0.04 mg/kg. Ophthalmic ointment was placed in both eyes and anesthesia was induced with ∼1% isoflurane gas. Heart rate, respiration, body temperature, and blood oxygen saturation were continuously monitored. An intravenous catheter was placed using aseptic technique in either the cephalic or saphenous vein. The radiotracer was produced to provide ∼2.0 mCi of \[^11^C\]raclopride in a volume no greater than 0.75 mL injected at 0.2 mL per 30 s at ∼10:00 h. The mass (0.17 ± 0.02 μg; mean ± SEM) and specific activity (4.3 ± 0.3 Ci/μmol) of \[^11^C\]raclopride administered to each monkey did not differ significantly across the three treatment conditions. After administration, the catheter was flushed with an amount of heparinized saline equivalent to the volume of the catheter.

Fully three-dimensional dynamic emission data were then collected for 60 min on a microPET R4 (Siemens Preclinical Solutions, Knoxville, TN) using an energy window of 250--750 keV and 137 successive time frames of increasing duration (14 at 5 s, 29 at 10 s, 45 at 20 s, 30 at 40 s, 19 at 60 s). The microPET scanner has 96 scintillation detector modules compactly arranged in a 14.8 cm diameter ring with an axial length of 7.8 cm. The tomograph has a spatial resolution of 1.85 mm full-width at half-maximum (FWHM) in the axial direction and 1.66 mm FWHM in the transaxial direction, which provides linear resolution of ∼2.5 mm in all three dimensions. Resulting emission data were used to compute \[^11^C\]raclopride binding for each voxel with a simplified kinetic model that uses the cerebellum as a reference brain region devoid of DRD2/3 ([@bib18]).

Whole brain anatomical data were acquired with MRI in separate sessions on a Signa 3T scanner (General Electric, Milwaukee, WI) at 9.5 years of age (range 8.4--10.3 years). Squirrel monkeys were sedated as described above and MRI was conducted with the following three-dimensional inversion recovery prepared fast spoiled gradient pulse sequence: TR = 12 ms, TE = 3 ms, TI = 300 ms, flip angle = 15, NEX = 4, matrix = 160 × 160, FOV = 8 cm, voxel size = 0.5 × 0.5 × 0.5 mm, slice thickness = 0.5 mm, gap = 0 mm, total scan time = 18 min. PET data were spatially co-registered to MRI data ([Fig. 1](#fig1){ref-type="fig"}) using SPM8 software ([www.fil.ion.ucl.ac.uk/spm/](http://www.fil.ion.ucl.ac.uk/spm/){#intref0010}). \[^11^C\]raclopride binding measures (BP~ND~) were determined for dorsal caudate nucleus, dorsal putamen, and ventral striatum as defined elsewhere ([@bib31]).

2.4. Data analysis {#sec2.4}
------------------

Mixed factor analysis of variance (ANOVA) was used to assess BP~ND~ measures. Stress inoculation (NS, SI, SI + Mom) was considered a between-subjects factor with striatal region (caudate, putamen, ventral striatum) and brain side (left, right) considered within-subjects factors. Body weight was included as a statistical covariate in keeping with suggestions for small primate PET neuroimaging ([@bib34]).

Post hoc pairwise comparisons with the NS control treatment condition were conducted with Dunnett tests. Post hoc comparisons between striatal regions were conducted with Bonferroni corrections and comparisons between SI and SI + Mom treatment conditions were conducted with t-tests. Effect sizes were determined using Cohen\'s *d* and associations between DRD2/3 BP~ND~ measures and previously reported cognitive control errors ([@bib42]) were assessed with Pearson correlation coefficients. All test statistics were evaluated with two-tailed probabilities at P \< 0.05.

3. Results {#sec3}
==========

Significant stress inoculation (F(2,20) = 4.01, P = 0.034) and striatal region (F(2,40) = 37.61, P \< 0.001) main effects were discerned in the 3-way ANOVA. As expected, DRD2/3 BP~ND~ was greater in caudate and putamen compared to ventral striatum (P \< 0.001). Across striatal regions, DRD2/3 BP~ND~ was respectively 9.3% and 10.7% greater in SI and SI + Mom squirrel monkeys compared to NS controls. Laterality main effects and all of the interactions were not statistically significant.

The 3-way ANOVA was decomposed to separately examine each striatal region with left and right brain sides combined ([Fig. 2](#fig2){ref-type="fig"}). Significant stress inoculation effects were discerned for ventral striatum (F(2,20) = 4.73, P = 0.021) and caudate (F(2,20) = 3.56, P = 0.048) but not putamen. Squirrel monkeys from the SI condition did not differ from SI + Mom squirrel monkeys in any of the striatal regions. Post hoc Dunnett tests established that DRD2/3 BP~ND~ was greater in ventral striatum for both SI (P = 0.041) and SI + Mom (P = 0.037) squirrel monkeys compared to NS controls. Dunnett tests likewise established that DRD2/3 BP~ND~ was greater for SI + Mom squirrel monkeys compared to NS controls in caudate (P = 0.038) but not putamen ([Fig. 2](#fig2){ref-type="fig"}).

Effect size estimates confirmed that DRD2/3 regulation by stress inoculation varied systematically across striatal regions. For the SI and SI + Mom conditions combined, treatment effects relative to the NS condition were greatest in ventral striatum (*d* = 1.41) followed by caudate (*d* = 1.07) and putamen (*d* = 0.78). Differences between regions diminished the overall increase described above for stress inoculation main effects across striatal regions. Effects in ventral striatum were the most robust with DRD2/3 BP~ND~ measures respectively 22.1% and 21.8% greater in SI and SI + Mom squirrel monkeys compared to NS controls.

Behavioral assessments of cognitive control from an earlier study ([@bib42]) were completed for 6 of 7 SI squirrel monkeys and 7 of 9 NS squirrel monkeys. Cognitive control tests were not conducted with any of the SI + Mom squirrel monkeys. Similar DRD2/3 BP~ND~ measures in SI and SI + Mom squirrel monkeys suggest that increased DRD2/3 availability relative to NS controls ([Fig. 2](#fig2){ref-type="fig"}) reflects stress inoculation and not subsequent testing effects.

Cognitive control errors for SI and NS squirrel monkeys analyzed together were inversely correlated with bilateral measures of DRD2/3 availability in ventral striatum (r = −0.62, df 11, P = 0.02) but not caudate (r = −0.45, df 11, P = 0.12) nor putamen (r = −0.32, df 11, P = 0.29). Higher DRD2/3 availability in ventral striatum correlated with fewer cognitive control errors ([Fig. 3](#fig3){ref-type="fig"}) and the correlation largely reflects group differences between SI and NS squirrel monkeys. The correlation was nearly significant, however, for NS squirrel monkeys analyzed alone (r = −0.71, df 5, P = 0.076) but not for SI squirrel monkeys with higher overall levels of DRD2/3 availability and fewer cognitive control errors.

4. Discussion {#sec4}
=============

Significant stress inoculation and striatal region main effects for DRD2/3 availability were detected *in vivo* by neuroimaging. DRD2/3 availability was greater in caudate and putamen compared to ventral striatum. DRD2/3 availability in ventral striatum was also consistently greater in stress inoculated squirrel monkeys compared to no-stress controls. Squirrel monkeys exposed to stress inoculation in the presence of their mother did not differ from squirrel monkeys exposed to stress inoculation without maternal companionship. Similar effects in different social contexts extend the generality of our findings and together suggest that stress inoculation increases striatal DRD2/3 availability as a correlate of cognitive control in squirrel monkeys.

In natural and semi-natural conditions squirrel monkey mothers and other group members intermittently leave newly weaned offspring beginning at 3--6 months of age to forage for food on their own ([@bib2], [@bib26]). Initially, brief intermittent separations studied in controlled experimental conditions elicit distress peep-calls and increase plasma levels of the stress hormone cortisol with partial habituation of these measures observed over repeated separations ([@bib6], [@bib21]). Later in life, squirrel monkeys exposed to intermittent separations show fewer behavioral indications of anxiety, diminished stress levels of cortisol, and enhanced sensitivity to glucocorticoid feedback regulation of the hypothalamic--pituitary--adrenal (HPA) axis compared to squirrel monkeys not exposed to prior separations ([@bib28], [@bib29]). Whereas severe forms of chronic stress impair HPA axis regulation and induce anxiety in macaque monkeys ([@bib37], [@bib44]), intermittent separations that simulate naturally occurring but stressful conditions mimic the effects of stress inoculation in humans.

In an earlier study of cognitive control conducted at 1.5 years of age, stress inoculated squirrel monkeys exposed to prior intermittent separations performed significantly better than control squirrel monkeys not exposed to prior separations ([@bib39]). Performance on the same cognitive test in marmoset monkeys and macaque monkeys is impaired by lesions of prefrontal cortex ([@bib11], [@bib12], [@bib56]) but not lesions of hippocampus ([@bib10]). In a different sample of squirrel monkeys from those examined here, stress inoculation early in life increased ventromedial prefrontal cortical volumes compared to controls ([@bib27]). Larger volumes do not reflect increased cortical thickness but instead represent surface area expansion of ventromedial prefrontal cortex due to growth and maturation of underlying white matter ([@bib23]).

To determine whether improvements in cognitive control of impulsivity continue on into adulthood, we tested a subset of the same squirrel monkeys as those examined here using different procedures at 3.5 years of age to assess inhibition of a motivated pre-potent response ([@bib42]). Stress inoculated squirrel monkeys exposed to prior intermittent separations again performed better than control squirrel monkeys not exposed to prior separations ([@bib42]). Moreover, performance at 3.5 years correlated with cognitive control measures collected at 1.5 years of age ([@bib42]). These findings suggest that stress inoculation early in life induces enduring trait-like transformations in cognitive control of impulsivity.

Cognitive control of impulsive behavior is a complex function mediated by multiple neural mechanisms. Larger ventromedial prefrontal size in humans predicts diminished impulsivity ([@bib30]) and prefrontal cortical regions interact with striatal dopamine systems to regulate cognitive control ([@bib22]). Studies of rats, monkeys, and humans have found that impulsive motivation for psychostimulant drugs is associated with low striatal DRD2/3 measures ([@bib9], [@bib35], [@bib51], [@bib55]) and high striatal DRD2/3 availability in humans has been linked to resilience against addictions ([@bib53], [@bib54]). Pharmacological DRD2/3 agonists decrease impulsive behavior in rats ([@bib14]) and improve reversal learning as an index of cognitive control in humans dependent on psychostimulant drugs ([@bib13]).

We found that DRD2/3 availability was greater in squirrel monkey caudate and putamen compared to ventral striatum as observed in PET studies of humans ([@bib31]) and other non-human primates ([@bib16]). DRD2/3 availability was also greater in stress inoculated squirrel monkeys compared to no-stress controls. Stress inoculation effects were greatest in ventral striatum followed by caudate and putamen. Differences between striatal regions in neuroanatomical connections and functions ([@bib20], [@bib5]) support our finding that enhanced cognitive control correlated with higher DRD2/3 availability in ventral striatum. Pharmacological mimicry of increased DRD2/3 availability by stress inoculation may therefore provide a novel target for new treatments of psychiatric disorders in humans that involve deficits in cognitive control.

Our results should be interpreted in the context of potential limitations. Findings from females may or may not hold true for males. Behavioral measures of cognitive control were not collected from all monkeys which limited the size of samples used for correlations but allowed assessment of stress inoculation versus subsequent testing effects. The \[^11^C\]raclopride PET radiotracer primarily binds dopamine D2 receptors ([@bib36]) but also D3 receptors in ventral striatum ([@bib19]) and does not distinguish pre-versus post-synaptic locations. DRD2/3 BP~ND~ measures also reflect receptor availability and not receptor densities because *in vivo* dopamine levels affect \[^11^C\]raclopride binding ([@bib25]). Nevertheless, *in vivo* PET measures of DRD2/3 availability correlate with *in vitro* estimates of striatal DRD2/3 densities in vervet monkeys ([@bib17]). Moreover, cerebrospinal fluid levels of the dopamine metabolite homovanillic acid do not differ significantly in stress inoculated squirrel monkeys compared to controls ([@bib41]). Lastly, the search for drugs that mimic increased DRD2/3 signaling as a target for new clinical interventions must contend with unwanted side effects ([@bib22]).

5. Conclusions {#sec5}
==============

We found stress inoculation and striatal region main effects for DRD2/3 availability in squirrel monkeys. DRD2/3 availability was greater in caudate and putamen compared to ventral striatum. DRD2/3 availability in ventral striatum was also consistently greater in stress inoculated squirrel monkeys compared to no-stress controls. Squirrel monkeys exposed to stress inoculation in the presence of their mother did not differ from squirrel monkeys exposed to stress inoculation without maternal companionship. Similar effects in different social contexts extend the generality of our findings and together suggest that stress inoculation increases striatal DRD2/3 availability as a correlate of cognitive control in squirrel monkeys.
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![Axial (top) and coronal (bottom) images of neuroanatomy (MRI) and DRD2/3 availability (PET) detected *in vivo* by \[^11^C\]raclopride binding in squirrel monkey brain.](gr1){#fig1}

![Stress inoculation effects on DRD2/3 availability in ventral striatum, caudate, and putamen. Data from individual squirrel monkeys are plotted for the no-stress control (NS), stress inoculated alone (SI), and stress inoculated with mother (SI + Mom) treatment conditions. Horizontal bars signify treatment condition means and asterisks represent significant Dunnett test comparisons with the NS control condition (P \< 0.05). DRD2/3 BP~ND~ measures reflect left and right brain sides combined. Note different y-axis measurement scales for ventral striatum compared to caudate and putamen.](gr2){#fig2}

![Correlation between DRD2/3 availability in ventral striatum and cognitive control errors (r = −0.62, df 11, P = 0.02) for squirrel monkeys from the no-stress control (NS, triangles) and stress inoculated alone (SI, squares) treatment conditions. Cognitive control errors were assessed as described elsewhere ([@bib42]) and represent the number of straight reaches on test trials with the box opening oriented left or right. DRD2/3 BP~ND~ for ventral striatum reflects left and right brain sides combined. Linear regression and 95% confidence intervals are depicted.](gr3){#fig3}
